Marker Therapeutics, Inc. (MRKR)

1.84 +0.13 (+7.60%) USD  |  NASDAQ  |  Jan 14, 16:00
1.83 -0.01 (-0.54%) After-Hours: 20:00
More

Marker Therapeutics Rent and Landing Expense (Quarterly)

Rent and Landing Expense (Quarterly) Chart

View Rent and Landing Expense (Quarterly) for MRKR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Rent and Landing Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Rent and Landing Expense (Quarterly) Range, Past 5 Years

View Rent and Landing Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Rent and Landing Expense (Quarterly) Benchmarks

View Rent and Landing Expense (Quarterly) Benchmarks
Start Trial
ADMA Biologics, Inc. Upgrade
Viridian Therapeutics, Inc. Upgrade
Neurocrine Biosciences, Inc. Upgrade
Kiniksa Pharmaceuticals International Plc --
AIM ImmunoTech, Inc. Upgrade